20VC: Why Being First To Market Does Not Matter, Why You Do Not Have Defensibility on Day 1, How to Analyse Market Size and Present it to Investors, Vitamins vs Painkillers; Do Vitamins Survive Recessions and Good vs Great Messaging with Guy Podjarny @ Sn | The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch | Podwise
20VC: Why Being First To Market Does Not Matter, Why You Do Not Have Defensibility on Day 1, How to Analyse Market Size and Present it to Investors, Vitamins vs Painkillers; Do Vitamins Survive Recessions and Good vs Great Messaging with Guy Podjarny @ Sn
This episode explores key insights into market strategy, startup success, and effective investing. It emphasizes the importance of assessing long-term relevance over mere "first to market" status, embracing failure and learning from startups, leveraging empathy and analysis in sales, quantifying market value, differentiating products and messaging, and leveraging the Seven Powers framework to build sustainable, superior, and significant businesses. Listeners will gain valuable insights into achieving product-market fit, outplaying incumbents, avoiding common angel investor mistakes, and navigating the complexities of angel investing and venture capital partnerships.
